BRIEF-Allergan And Richter Announce Positive Topline Results From Phase 3 Study Of Cariprazine For Treatment Of Bipolar I Depression
December 18, 2017 at 08:11 AM EST
* ALLERGAN AND RICHTER ANNOUNCE POSITIVE TOPLINE RESULTS FROM PHASE 3 STUDY OF CARIPRAZINE FOR THE TREATMENT OF BIPOLAR I DEPRESSION